Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective, Multicenter, Randomized, Evaluator-Blinded, Confirmatory Study to Evaluate the Efficacy and Safety of LEXURE for Improving Language Function in Patients With Post-Stroke Aphasia

NCT07570264 is registered in ClinicalTrials.gov with Nunaps Inc as lead sponsor.

NCT NCT07570264
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07570264 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective, Multicenter, Randomized, Evaluator-Blinded, Confirmatory Study to Evaluate the Efficacy and Safety of LEXURE for Improving Language Function in Patients With Post-Stroke Aphasia
Lead sponsor
Nunaps Inc
Phase
Not applicable
Overall status
Recruiting
Start date
April 16, 2026
Completion date
December 30, 2026
Enrollment
116 (estimated)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

aphasia